Chimeric Antigen Receptor (CAR) T-cells have emerged as a promising immune effector cell-based therapy. With promising results and approval for the treatment of hematological malignancies, we discuss the scope of this novel therapeutic modality in systemic autoimmune diseases and immune-mediated inflammatory disorders refractory to conventional and biological disease-modifying agents.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
therapy promising
8
autoimmune diseases
8
car t-cell
4
t-cell therapy
4
promising modality
4
modality autoimmune
4
diseases chimeric
4
chimeric antigen
4
antigen receptor
4
receptor car
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!